Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 16:46:11 UTC |
---|
Update Date | 2021-09-26 23:12:00 UTC |
---|
HMDB ID | HMDB0256380 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide |
---|
Description | 5-chloro-N-[1-(4-fluorophenyl)-3-(C-hydroxycarbonimidoyl)-1H,4H,5H-benzo[g]indazol-8-yl]-2-(4-methylpiperazin-1-yl)pyridine-4-carboximidic acid belongs to the class of organic compounds known as pyridinylpiperazines. Pyridinylpiperazines are compounds containing a pyridinylpiperazine skeleton, which consists of a pyridine linked (not fused) to a piperazine by a bond by a single bond that is not part of a ring. Based on a literature review very few articles have been published on 5-chloro-N-[1-(4-fluorophenyl)-3-(C-hydroxycarbonimidoyl)-1H,4H,5H-benzo[g]indazol-8-yl]-2-(4-methylpiperazin-1-yl)pyridine-4-carboximidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). 8-(5-chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1h-benzo[g]indazole-3-carboxamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CN1CCN(CC1)C1=NC=C(Cl)C(=C1)C(=O)NC1=CC2=C(CCC3=C2N(N=C3C(N)=O)C2=CC=C(F)C=C2)C=C1 InChI=1S/C29H27ClFN7O2/c1-36-10-12-37(13-11-36)25-15-23(24(30)16-33-25)29(40)34-19-6-2-17-3-9-21-26(28(32)39)35-38(27(21)22(17)14-19)20-7-4-18(31)5-8-20/h2,4-8,14-16H,3,9-13H2,1H3,(H2,32,39)(H,34,40) |
---|
Synonyms | Value | Source |
---|
5-Chloro-N-[1-(4-fluorophenyl)-3-(C-hydroxycarbonimidoyl)-1H,4H,5H-benzo[g]indazol-8-yl]-2-(4-methylpiperazin-1-yl)pyridine-4-carboximidate | Generator | PHA 408 | MeSH |
|
---|
Chemical Formula | C29H27ClFN7O2 |
---|
Average Molecular Weight | 560.03 |
---|
Monoisotopic Molecular Weight | 559.189879 |
---|
IUPAC Name | N-[3-carbamoyl-1-(4-fluorophenyl)-1H,4H,5H-benzo[g]indazol-8-yl]-5-chloro-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide |
---|
Traditional Name | N-[3-carbamoyl-1-(4-fluorophenyl)-4H,5H-benzo[g]indazol-8-yl]-5-chloro-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN1CCN(CC1)C1=NC=C(Cl)C(=C1)C(=O)NC1=CC2=C(CCC3=C2N(N=C3C(N)=O)C2=CC=C(F)C=C2)C=C1 |
---|
InChI Identifier | InChI=1S/C29H27ClFN7O2/c1-36-10-12-37(13-11-36)25-15-23(24(30)16-33-25)29(40)34-19-6-2-17-3-9-21-26(28(32)39)35-38(27(21)22(17)14-19)20-7-4-18(31)5-8-20/h2,4-8,14-16H,3,9-13H2,1H3,(H2,32,39)(H,34,40) |
---|
InChI Key | ZLEZHGHFWIHCGU-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyridinylpiperazines. Pyridinylpiperazines are compounds containing a pyridinylpiperazine skeleton, which consists of a pyridine linked (not fused) to a piperazine by a bond by a single bond that is not part of a ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazinanes |
---|
Sub Class | Piperazines |
---|
Direct Parent | Pyridinylpiperazines |
---|
Alternative Parents | |
---|
Substituents | - Pyridinylpiperazine
- N-arylpiperazine
- Phenylpyrazole
- Naphthalene
- Pyridinecarboxamide
- Pyridine carboxylic acid or derivatives
- 2-heteroaryl carboxamide
- Pyrazole-5-carboxamide
- Dialkylarylamine
- Aminopyridine
- Fluorobenzene
- Halobenzene
- N-methylpiperazine
- N-alkylpiperazine
- Monocyclic benzene moiety
- Aryl halide
- Aryl fluoride
- Aryl chloride
- Benzenoid
- Pyridine
- Imidolactam
- Vinylogous halide
- Azole
- Pyrazole
- Heteroaromatic compound
- Secondary carboxylic acid amide
- Tertiary amine
- Tertiary aliphatic amine
- Primary carboxylic acid amide
- Carboxamide group
- Amino acid or derivatives
- Carboxylic acid derivative
- Azacycle
- Hydrocarbon derivative
- Amine
- Organic nitrogen compound
- Organohalogen compound
- Organochloride
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Organic oxide
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 228.146 | 30932474 | DeepCCS | [M-H]- | 226.116 | 30932474 | DeepCCS | [M-2H]- | 259.358 | 30932474 | DeepCCS | [M+Na]+ | 234.059 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,1TMS,isomer #1 | CN1CCN(C2=CC(C(=O)NC3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N[Si](C)(C)C)=C(Cl)C=N2)CC1 | 5063.2 | Semi standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,1TMS,isomer #1 | CN1CCN(C2=CC(C(=O)NC3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N[Si](C)(C)C)=C(Cl)C=N2)CC1 | 4420.9 | Standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,1TMS,isomer #1 | CN1CCN(C2=CC(C(=O)NC3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N[Si](C)(C)C)=C(Cl)C=N2)CC1 | 6373.1 | Standard polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,1TMS,isomer #2 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(N)=O)[Si](C)(C)C)=C(Cl)C=N2)CC1 | 4945.8 | Semi standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,1TMS,isomer #2 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(N)=O)[Si](C)(C)C)=C(Cl)C=N2)CC1 | 4328.7 | Standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,1TMS,isomer #2 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(N)=O)[Si](C)(C)C)=C(Cl)C=N2)CC1 | 6685.3 | Standard polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,2TMS,isomer #1 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N[Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=N2)CC1 | 4828.8 | Semi standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,2TMS,isomer #1 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N[Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=N2)CC1 | 4347.6 | Standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,2TMS,isomer #1 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N[Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=N2)CC1 | 5972.9 | Standard polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,2TMS,isomer #2 | CN1CCN(C2=CC(C(=O)NC3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=N2)CC1 | 5014.5 | Semi standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,2TMS,isomer #2 | CN1CCN(C2=CC(C(=O)NC3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=N2)CC1 | 4572.4 | Standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,2TMS,isomer #2 | CN1CCN(C2=CC(C(=O)NC3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=N2)CC1 | 6070.5 | Standard polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,3TMS,isomer #1 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=N2)CC1 | 4821.7 | Semi standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,3TMS,isomer #1 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=N2)CC1 | 4452.6 | Standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,3TMS,isomer #1 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=N2)CC1 | 5667.0 | Standard polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,1TBDMS,isomer #1 | CN1CCN(C2=CC(C(=O)NC3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N[Si](C)(C)C(C)(C)C)=C(Cl)C=N2)CC1 | 5246.4 | Semi standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,1TBDMS,isomer #1 | CN1CCN(C2=CC(C(=O)NC3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N[Si](C)(C)C(C)(C)C)=C(Cl)C=N2)CC1 | 4635.5 | Standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,1TBDMS,isomer #1 | CN1CCN(C2=CC(C(=O)NC3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N[Si](C)(C)C(C)(C)C)=C(Cl)C=N2)CC1 | 6379.9 | Standard polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,1TBDMS,isomer #2 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(N)=O)[Si](C)(C)C(C)(C)C)=C(Cl)C=N2)CC1 | 5096.3 | Semi standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,1TBDMS,isomer #2 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(N)=O)[Si](C)(C)C(C)(C)C)=C(Cl)C=N2)CC1 | 4512.9 | Standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,1TBDMS,isomer #2 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(N)=O)[Si](C)(C)C(C)(C)C)=C(Cl)C=N2)CC1 | 6674.3 | Standard polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,2TBDMS,isomer #1 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=N2)CC1 | 5123.5 | Semi standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,2TBDMS,isomer #1 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=N2)CC1 | 4692.3 | Standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,2TBDMS,isomer #1 | CN1CCN(C2=CC(C(=O)N(C3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=N2)CC1 | 5997.1 | Standard polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,2TBDMS,isomer #2 | CN1CCN(C2=CC(C(=O)NC3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=N2)CC1 | 5326.0 | Semi standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,2TBDMS,isomer #2 | CN1CCN(C2=CC(C(=O)NC3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=N2)CC1 | 4890.6 | Standard non polar | 33892256 | 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide,2TBDMS,isomer #2 | CN1CCN(C2=CC(C(=O)NC3=CC=C4CCC5=C(C4=C3)N(C3=CC=C(F)C=C3)N=C5C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=N2)CC1 | 6044.3 | Standard polar | 33892256 |
|
---|